SCHWARZ PHARMA LIKELY TO LURE SUITORS

A A

Schwarz Pharma AG may be the next German drugmaker to attract suitors in an industry that's starved for new products. The company's shares have gained 27% in a month after rival Merck KGaA dropped plans to buy Schering AG, fueling speculation it may turn to Schwarz. Monheim, Germany-based Schwarz, once one of the country's biggest generic-drug makers, now develops its own medicines and its products may generate more than $2.5 billion in annual sales.

The Financial Express (http://www.financialexpress.com/fe_full_story.php?content_id=133747)